| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.006 |